Steward Partners Investment Advisory’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$124K Sell
990
-82
-8% -$10.3K ﹤0.01% 1985
2025
Q1
$147K Sell
1,072
-409
-28% -$56K ﹤0.01% 1799
2024
Q4
$226K Sell
1,481
-691
-32% -$106K ﹤0.01% 1534
2024
Q3
$421K Buy
2,172
+430
+25% +$83.4K ﹤0.01% 1180
2024
Q2
$404K Sell
1,742
-129
-7% -$29.9K ﹤0.01% 1150
2024
Q1
$403K Buy
1,871
+71
+4% +$15.3K ﹤0.01% 1149
2023
Q4
$466K Sell
1,800
-9,400
-84% -$2.43M 0.01% 1030
2023
Q3
$2.88M Buy
11,200
+9,389
+518% +$2.41M 0.04% 376
2023
Q2
$516K Sell
1,811
-37
-2% -$10.5K 0.01% 924
2023
Q1
$514K Sell
1,848
-157
-8% -$43.7K 0.01% 917
2022
Q4
$555K Buy
2,005
+63
+3% +$17.4K 0.01% 878
2022
Q3
$519K Buy
1,942
+14
+0.7% +$3.74K 0.01% 845
2022
Q2
$393K Sell
1,928
-7
-0.4% -$1.43K 0.01% 940
2022
Q1
$408K Sell
1,935
-166
-8% -$35K 0.01% 997
2021
Q4
$504K Buy
2,101
+173
+9% +$41.5K 0.01% 931
2021
Q3
$546K Sell
1,928
-123
-6% -$34.8K 0.01% 873
2021
Q2
$710K Sell
2,051
-718
-26% -$249K 0.01% 801
2021
Q1
$775K Buy
2,769
+469
+20% +$131K 0.01% 733
2020
Q4
$563K Sell
2,300
-83
-3% -$20.3K 0.01% 724
2020
Q3
$676K Buy
2,383
+394
+20% +$112K 0.02% 588
2020
Q2
$532K Buy
1,989
+398
+25% +$106K 0.02% 609
2020
Q1
$503K Sell
1,591
-679
-30% -$215K 0.02% 560
2019
Q4
$673K Sell
2,270
-151
-6% -$44.8K 0.02% 557
2019
Q3
$563K Buy
2,421
+301
+14% +$70K 0.02% 550
2019
Q2
$495K Sell
2,120
-741
-26% -$173K 0.02% 566
2019
Q1
$676K Sell
2,861
-924
-24% -$218K 0.03% 441
2018
Q4
$1.14M Sell
3,785
-144
-4% -$43.3K 0.06% 311
2018
Q3
$1.39M Sell
3,929
-826
-17% -$292K 0.07% 278
2018
Q2
$1.38M Buy
4,755
+52
+1% +$15.1K 0.08% 242
2018
Q1
$1.29M Buy
4,703
+542
+13% +$148K 0.09% 231
2017
Q4
$1.33M Buy
4,161
+1,629
+64% +$519K 0.1% 201
2017
Q3
$792K Buy
2,532
+1,041
+70% +$326K 0.08% 216
2017
Q2
$404K Buy
1,491
+489
+49% +$132K 0.05% 306
2017
Q1
$273K Buy
1,002
+552
+123% +$150K 0.04% 288
2016
Q4
$127K Buy
+450
New +$127K 0.06% 225